Skip to content
Subscriber Only

J&J’s Janssen Must Pay $4 Million Over Topamax, Jury Says

Johnson & Johnson’s Janssen Pharmaceutical unit must pay $4.02 million in a lawsuit claiming that its seizure drug Topamax caused birth defects, a Philadelphia jury said.

Jurors in state court deliberated less than an hour before rendering a verdict in favor of Virginia resident April Czimmer who took the drug for six months and gave birth to a boy with cleft lip. Czimmer said her son Blake, born in September 2007, had injuries requiring four surgeries.